Medibiofarma
Spain - NavarrraBiotechnology
Focus: Medibiofarma is a Spanish biotech focused on small molecule drug discovery across oncology, immunology, and neurology. Founded in 2016, the company is in early clinical stages with a portfolio of Phase 1 and Phase 2 candidates.
Profile data last refreshed 2d ago · AI intelligence enriched 1w ago
Open Jobs
0
About Medibiofarma
AI assessmentNot HiringNo open roles listed right now. Follow Medibiofarma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MBF-015 4 mg oral capsule
Safety and PharmacokineticClinical Trials (1)
NCT06049147Study to Assess the Safety and Tolerability of MBF-015 in Healthy Young Volunteers
Phase 1Help build intelligence for Medibiofarma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.